EP Patent

EP2105389A1 — Tearable packages for pharmaceutical product and method

Assigned to Aquestive Therapeutics Inc · Expires 2009-09-30 · 17y expired

What this patent protects

An aspect of the invention provides a tearable package (10) for a pharmaceutical product (40) including: (i) a first layer (12) including a sheet of flexible material; (ii) a second layer (14) including a sheet of flexible material; the layers being overlaid and fused together at…

USPTO Abstract

An aspect of the invention provides a tearable package (10) for a pharmaceutical product (40) including: (i) a first layer (12) including a sheet of flexible material; (ii) a second layer (14) including a sheet of flexible material; the layers being overlaid and fused together at a perimetrical sealing region (20), the fused layers (12,14) defining a cavity (16) therebetween for the storage of the pharmaceutical product (40); wherein one of the layers (12) has a discontinuous region (30) in the sealing region (20); and wherein the package (10) may be folded through the discontinuous region (30) to be torn such that the pharmaceutical contents may be removed.

Drugs covered by this patent

Patent Metadata

Patent number
EP2105389A1
Jurisdiction
EP
Classification
Expires
2009-09-30
Drug substance claim
No
Drug product claim
No
Assignee
Aquestive Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.